The Ensera Alliance Network is built to create a true win-win ecosystem; bringing together capabilities, expertise, and technologies from across the industry to help our partners grow while giving Pharma a more connected, efficient path to commercialization. By combining Ensera’s capabilities with those of our strategic partners, we can solve complex customer challenges faster, reduce supply chain risk, and ultimately deliver greater value to Pharma.
- Darren Hieber, Sales Lead USA & Alliances, Ensera
Uniting trusted expertise to accelerate complex healthcare products to market.
Proven collaboration. Faster paths to market.
The Ensera Alliance Network brings together a select group of trusted specialists across the pharmaceutical and drug delivery supply chain in both North America and Europe.
These partnerships are built on technical, quality, operational and commercial alignment, strengthened through successful projects and longstanding working relationships.
By connecting complementary expertise through proven ways of working, Ensera helps reduce complexity, simplify supply chains and minimize transfer risk.
For your pharmaceutical programs, this means fewer handovers, clearer accountability and smoother progression from development through commercialization.
The Ensera Alliance Network
-
Platform partner -
Platform partner -
Platform partner -
Fill-finish partner - Fill-finish partner
Get in touch to explore how Ensera and our partners can get you to market smoothly
Platform device manufacturers
Ensera works closely with leading drug delivery device manufacturers whose technologies, quality standards and ways of working align with our own.
As an approved final assembly partner for these injectable platforms, we guide and support pharma companies as they move from device selection, and validation through final assembly and commercialization, including labeling, secondary packing, kitting, serialization, testing and where relevant, sterilization management.
We are ready to assemble: BD Physioject, SHL Molly (1ml & 2.25ml), Ypsomed Ypsomate (1ml & 2.25ml) and Stevanato Group’s Aidaptus and Alina platforms.
The result is a proven route to market that reduces transfer risk, simplifies coordination and helps accelerate launch timelines.
Fill-finish partners
Ensera partners with specialist fill-finish organizations that share our focus on flexibility, responsiveness and support for low-to-medium volume pharmaceutical programs.
Through established technical and operational relationships, we provide a seamless transition from aseptic filling into final assembly and commercialization.
Together, we deliver an integrated service that connects two key, yet distinct stages of your value chain, giving you a smoother, more efficient path to market.
We're ready to help you reach your market ambitions
Find out how the Ensera Alliance Network can help get your pharmaceutical product to market
Partnerships in action
- Case study
Supporting ultra‑low‑volume orphan drug launches with complex secondary packaging
Discover how Ensera provided an orphan drug customer with flexible secondary packaging, labeling, and kitting for highly specialized injectable products in very low volumes.
Read case study - Case study
Enabling smooth, dual-market delivery of a kitted PFS biosimilar requiring terminal sterilization
When a global biosimilar company needed a flexible final assembly, kitting and packing partner with proven sterilization expertise, they came to Ensera. We were able to provide agile capacity, sterile packaging advice, and sterilization management to support a smooth and timely launch in Europe, while preparing the program for future expansion into North America.
Read case study - Case study
Accelerating European market entry for Asia-manufactured biosimilars
An Asian biosimilar company needed a flexible European localization partner capable of converting large bulk batches into many small, country-specific SKUs at speed. We delivered a cold chain-enabled solution designed for agility, complexity and accelerated market entry.
Read case study
